Celling Biosciences ART PRP products are engineered to effectively and efficiently concentrate platelets and growth factors from whole blood. The design allows a user to select the desired layer of the centrifuged stack in a controlled manner.
Celling Biosciences’ ART PRP surpasses the competition in every category. The device features a thumbwheel that allows users to selectively deconstruct the fluid stack to prepare customized PRP products.
ART PRP Plus
The ART PRP PLUS system processes autologous whole blood at the point of care. The system recovers a high percentage of platelets and growth factors by allowing a selection of concentrate from a patented controlled collection system in the centrifuged stack. The integrated filter allows for the ultrafiltration of proteins from the platelet poor plasma.
ART Two Step (pending FDA approval)
The ART PRP Two Step is anticipated for released in August of 2018.